A detailed history of Walleye Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Walleye Capital LLC holds 84,400 shares of NVS stock, worth $8.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
84,400
Previous 94,800 10.97%
Holding current value
$8.3 Million
Previous $10.1 Million 3.81%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $2.73 Million - $3.11 Million
25,743 Added 722.51%
29,306 $3.37 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $993,738 - $1.15 Million
-10,735 Reduced 75.08%
3,563 $379,000
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $1.36 Million - $1.55 Million
14,298 New
14,298 $1.38 Million
Q1 2019

May 15, 2019

SELL
$75.32 - $86.15 $358,146 - $409,643
-4,755 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $318,299 - $368,179
4,755 New
4,755 $410,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.